PCS12852, A NOVEL 5-HT4 AGONIST, IMPROVES GCSI SYMPTOM SCORES AND GASTRIC EMPTYING IN GASTROPARESIS PATIENTS

被引:0
|
作者
Das, Maya
Smythe-Peterkin, Shanique
McCallum, Richard W.
Parks, Kayla
Franks, Peter
Young, David
Bigora, Sian
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
212
引用
收藏
页码:S37 / S37
页数:1
相关论文
共 50 条
  • [21] 5ht4-Agonist (Mosapride) Improves the Clinical Symptoms in PPI-Resistant NERD Patients via Improvement of Gastric Emptying
    Futagami, Seiji
    Iwakiri, Katsuhiko
    Shindo, Tomotaka
    Kawagoe, Tetsuro
    Horie, Akane
    Shimpuku, Mayumi
    Gudis, Katya
    Miyake, Kazumasa
    Tsukui, Taku
    Sakamoto, Choitsu
    GASTROENTEROLOGY, 2009, 136 (05) : A529 - A530
  • [22] Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients
    Liu, Z
    Sakakibara, R
    Odaka, T
    Uchiyama, T
    Uchiyama, T
    Yamamoto, T
    Ito, T
    Asahina, M
    Yamaguchi, K
    Yamaguchi, T
    Hattori, T
    MOVEMENT DISORDERS, 2005, 20 (06) : 680 - 686
  • [23] Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients
    Sakakibara, R
    Uchiyama, T
    Liu, Z
    Yamamoto, T
    Ito, T
    Yamanishi, T
    Hattori, T
    NEUROUROLOGY AND URODYNAMICS, 2004, 23 (5-6) : 448 - 450
  • [24] Patients with gastroparesis have a decreased expression of the 5-Ht4(C) splice variant in the duodenum
    van Lelyveld, Niels
    Ter Linde, Jose
    Schipper, Marguerite
    Samsom, Melvin
    GASTROENTEROLOGY, 2006, 130 (04) : A431 - A432
  • [25] Design, synthesis and pharmacological characterization of novel amides as 5-HT4 receptor agonist
    Shinde, Anil
    Mohammed, Abdul Rasheed
    Saraf, Sangram Keshri
    Bhatta, Venugopala
    Kandukuri, Kirankumar
    Sastry, Kambhampati
    Subramanian, Ramkumar
    Mekala, Venkatreddy
    Bhyrapuneni, Gopinadh
    Benade, Vijay
    Jayarajan, Pradeep
    Nirogi, Ramakrishna
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [26] Pharmacokinetics of the novel 5-HT4 receptor agonist, DA-6886, in dogs
    Lee, Dae Young
    Kang, Hee Eun
    XENOBIOTICA, 2023, 53 (05) : 438 - 444
  • [27] Patients with gastroparesis have a decreased expression of the 5-HT4(C) splice variant in the duodenum
    van Lelyveld, N.
    Ter Linde, J.
    Schipper, M. E. I.
    Samsom, M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (10) : A11 - A11
  • [28] YH12852, a potent and highly selective 5-HT4 receptor agonist, significantly improves both upper and lower gastrointestinal motility in a guinea pig model of postoperative ileus
    Hussain, Z.
    Lee, Y. J.
    Yang, H.
    Jeong, E. J.
    Sim, J. Y.
    Park, H.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2017, 29 (10): : 1 - 6
  • [29] Ghrelin Agonist TZP-101 Improves Symptoms and Gastric Emptying in Diabetic Patients with Gastroparesis 2009 Presidential Poster
    McCallum, Richard
    Dimcevski, Georg
    Wo, John
    Hellstrom, Per
    Nowak, Thomas
    Gormsen, Lars
    Sarosiek, Irene
    Softeland, Eirik
    Pezzullo, John
    Shaughnessy, Laura
    Kosutic, Gordana
    Ejskjaer, Niels
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S43 - S44
  • [30] Prokinetic effects and mechanisms of a new 5-HT4 compound YKP10811 on gastric emptying in dogs
    Yin, J.
    Xu, X.
    Han, H.
    Kim, H.
    Chen, J. D. Z.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2010, 22 : 78 - 78